Human study · Supplements / medicine · 1 Oct 2026
In 58 people, a UV dose too low to redden the skin still left DNA damage, whether the dose came quickly or slowly
Source: QIMR Berghofer
What the research found
Study (human skin biopsies). Rachel Neale, David Whiteman, and colleagues at QIMR Berghofer describe the Low-Dose UV Study; ScienceDaily carried it on 1 October 2026. Fifty-eight people with light to olive skin had a patch of back skin exposed to lower-intensity ultraviolet (such as mid-morning) and higher-intensity ultraviolet (such as around noon) across several days, matched so the total dose could be compared. Biopsies showed DNA damage and a rise in p53, a protein that increases when skin cells are stressed, even when the dose was too small to turn the skin pink. Delivering the same dose slowly or quickly did not change that finding. Whiteman said the damage is not cancer itself; repeated incidental doses can add mutations over years. The release says sunlight also supports vitamin D and is a complete carcinogen, and that current advice is sun protection when the UV index is 3 or higher. The release names the paper as being in Photochemistry and Photobiology. The automatic journal line on the ScienceDaily page points at a different Nature Communications paper about nevus count, so that DOI is not used here. The release does not give ages or a sex split. Educational notes. This is not a vitamin D study and not advice to avoid daylight entirely.
Evidence level: Human study. A study in people, but an association isn't proof of cause.
More supplements / medicine news
- In mice, the experimental drug KCL-286 reduced DNA breaks and brain inflammation in an Alzheimer's model
- In aged rats, two weeks of the experimental drug cinaciguat cut circulating amyloid-beta about in half and brought LDL down to youthful levels
- In 104 people with a sudden retinal-artery blockage, papaverine use lined up with better functional vision in a retrospective comparison
- A Cell Metabolism letter questions whether a fasting GLP-1 level shows how many gut L-cells a person has
- In FDA reports, caffeine and stimulant supplement use was tied to cardiac arrest about 11 times more often, and 45 percent of those cardiovascular reports were ages 18 to 34